Chuang WL, Hu TH, Buggisch P, Moreno C, et al. Ledipasvir/Sofosbuvir for 8, 12, or 24 Weeks in Hepatitis C Patients Undergoing Dialysis for End-Stage Renal Disease. Am J Gastroenterol 2021;116:1924-1928.
PMID: 34465694